Ryan Logan to Fentanyl
This is a "connection" page, showing publications Ryan Logan has written about Fentanyl.
Connection Strength
3.434
-
Delorme TC, Vilca SJ, Logan RW. Acute and persistent sex-dependent disruptions of sleep-wake architecture induced by fentanyl self-administration in mice. Neuropharmacology. 2026 Jul 01; 292:110943.
Score: 0.909
-
Williams BR, Gamble MC, Singh N, Bryant CD, Logan BA, Logan RW. Sleep and circadian rhythm activity alterations during adolescence in a mouse model of neonatal fentanyl withdrawal syndrome. Neuroscience. 2025 03 17; 569:85-91.
Score: 0.841
-
Gamble MC, Miracle S, Williams BR, Logan RW. Endocannabinoid agonist 2-arachidonoylglycerol differentially alters diurnal activity and sleep during fentanyl withdrawal in male and female mice. Pharmacol Biochem Behav. 2024 07; 240:173791.
Score: 0.800
-
Gamble MC, Chuan B, Gallego-Martin T, Shelton MA, Puig S, O'Donnell CP, Logan RW. A role for the circadian transcription factor NPAS2 in the progressive loss of non-rapid eye movement sleep and increased arousal during fentanyl withdrawal in male mice. Psychopharmacology (Berl). 2022 Oct; 239(10):3185-3200.
Score: 0.707
-
Puig S, Shelton MA, Barko K, Seney ML, Logan RW. Sex-specific role of the circadian transcription factor NPAS2 in opioid tolerance, withdrawal and analgesia. Genes Brain Behav. 2022 09; 21(7):e12829.
Score: 0.177